NO974397D0 - Terminale karboksy- eller tetrazolgrupper inneholdende dialkyletere - Google Patents
Terminale karboksy- eller tetrazolgrupper inneholdende dialkyletereInfo
- Publication number
- NO974397D0 NO974397D0 NO974397A NO974397A NO974397D0 NO 974397 D0 NO974397 D0 NO 974397D0 NO 974397 A NO974397 A NO 974397A NO 974397 A NO974397 A NO 974397A NO 974397 D0 NO974397 D0 NO 974397D0
- Authority
- NO
- Norway
- Prior art keywords
- dialkyl ethers
- groups containing
- terminal carboxy
- containing dialkyl
- tetrazole groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/28—Saturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
- C07C47/37—Saturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
- C07C59/315—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/347—Saturated compounds containing more than one carboxyl group containing keto groups
- C07C59/353—Saturated compounds containing more than one carboxyl group containing keto groups containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Dental Preparations (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/409,780 US5648387A (en) | 1995-03-24 | 1995-03-24 | Carboxyalkylethers, formulations, and treatment of vascular diseases |
PCT/US1996/001639 WO1996030328A1 (en) | 1995-03-24 | 1996-02-05 | Terminal carboxy or tetrazole groups containing dialkyl ethers |
Publications (3)
Publication Number | Publication Date |
---|---|
NO974397D0 true NO974397D0 (no) | 1997-09-23 |
NO974397L NO974397L (no) | 1997-11-20 |
NO307878B1 NO307878B1 (no) | 2000-06-13 |
Family
ID=23621941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974397A NO307878B1 (no) | 1995-03-24 | 1997-09-23 | Terminale karboksy-gruppe inneholdende dialkyletere |
Country Status (27)
Country | Link |
---|---|
US (4) | US5648387A (no) |
EP (1) | EP0820428B1 (no) |
JP (1) | JP3885115B2 (no) |
KR (1) | KR100408612B1 (no) |
CN (1) | CN1100747C (no) |
AT (1) | ATE192732T1 (no) |
AU (1) | AU692359B2 (no) |
BG (1) | BG63534B1 (no) |
CA (1) | CA2215233C (no) |
CZ (1) | CZ289556B6 (no) |
DE (1) | DE69608268T2 (no) |
DK (1) | DK0820428T3 (no) |
EE (1) | EE03520B1 (no) |
ES (1) | ES2148733T3 (no) |
FI (1) | FI973713A (no) |
GR (1) | GR3034109T3 (no) |
HK (1) | HK1009438A1 (no) |
HU (1) | HUP9801825A3 (no) |
NO (1) | NO307878B1 (no) |
NZ (1) | NZ302170A (no) |
PL (1) | PL181673B1 (no) |
PT (1) | PT820428E (no) |
RU (1) | RU2191772C2 (no) |
SK (1) | SK282897B6 (no) |
UA (1) | UA46020C2 (no) |
WO (1) | WO1996030328A1 (no) |
ZA (1) | ZA962275B (no) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL119971A (en) | 1997-01-07 | 2003-02-12 | Yissum Res Dev Co | Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids |
PL343851A1 (en) * | 1997-12-12 | 2001-09-10 | Warner Lambert Co | Antihyperlipidemic statin-lp(a) inhibitor combinations |
NZ503982A (en) * | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
EP1481962A1 (en) * | 1997-12-12 | 2004-12-01 | Warner-Lambert Company LLC | New cholesterolemia-lowering carboxyalkylether compound |
US20030105154A1 (en) * | 2001-10-24 | 2003-06-05 | Bisgaier Charles Larry | Statin-carboxyalkylether combinations |
US6861555B2 (en) * | 2000-01-25 | 2005-03-01 | Warner-Lambert Company | Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
ES2257824T3 (es) * | 1998-01-28 | 2006-08-01 | Warner-Lambert Company Llc | Metodo para tratar la enfermedad de alzheimer. |
PL346980A1 (en) * | 1998-09-30 | 2002-03-11 | Warner Lambert Co | Method for preventing or delaying catheter-based revascularization |
EP1849760A1 (en) * | 1999-04-01 | 2007-10-31 | Esperion Therapeutics Inc. | Ether compounds, compositions, and uses thereof |
BR0009520A (pt) | 1999-04-01 | 2002-06-11 | Esperion Therapeutics Inc | Composto, método para sintetizar o mesmo, composição, metódos para o tratramento ou prevenção, em um paciente, de doença cardiovascular, dislipidemia, dislipoproteinemia, distúrbio de metabolismo de glucose, doença de alzheimer, sìndrome x ou sìndrome metabólica, septicemia, distúrbio trombótico, distúrbio associado com receptor ativado por proliferador de peroxissoma, obesidade, pancreatite, hipertensão, doença renal, câncer, inflamação, impotência, para reduzir o teor de gordura de carne de gado bovino, e, para reduzir o teor de colesterol de ovos de aves |
EP1259474B1 (en) | 2000-01-25 | 2009-05-13 | Warner-Lambert Company LLC | Calcium dicarboxylate ethers, methods of making same |
US20040092574A1 (en) * | 2000-02-07 | 2004-05-13 | Bisgaier Charles Larry | Statin-Lp(a) inhibitor combinations |
MXPA02009662A (es) * | 2000-04-26 | 2003-03-10 | Warner Lambert Co | Agentes antihipertensivos y su uso. |
IL153788A0 (en) * | 2000-07-14 | 2003-07-31 | Warner Lambert Co | Treatment of eating disorders using carboxyalkylethers |
US20040122091A1 (en) * | 2000-10-11 | 2004-06-24 | Esperion Therapeutics, Inc. | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
JP2004511453A (ja) | 2000-10-11 | 2004-04-15 | エスペリオン セラピューティクス,インコーポレイテッド | コレステロールの制御及び関連する使用のためのケトン化合物及び組成物 |
US7304093B2 (en) * | 2000-10-11 | 2007-12-04 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
CA2425678A1 (en) | 2000-10-11 | 2002-04-18 | Jean-Louis H. Dasseux | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
EP1351916A2 (en) * | 2000-10-11 | 2003-10-15 | Esperion Therapeutics Inc. | Ether compounds and compositions for cholesterol management and related uses |
CN101426763A (zh) | 2000-10-11 | 2009-05-06 | 埃斯佩里安医疗公司 | 用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物 |
US20030225123A1 (en) * | 2001-03-22 | 2003-12-04 | Auerbach Bruce Jeffrey | Antihypertensive agents and use |
US20040072903A1 (en) * | 2001-05-08 | 2004-04-15 | Auerbach Bruce Jeffrey | Carboxyalkylether-acat inhibitors combinations |
US20050020694A1 (en) * | 2001-10-11 | 2005-01-27 | Dasseux Jean-Louis Henri | Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
US20040192771A1 (en) * | 2001-10-11 | 2004-09-30 | Dasseux Jean-Louis Henri | Ether compounds and compositions for cholesterol management and related uses |
US20040204502A1 (en) * | 2001-10-11 | 2004-10-14 | Dasseux Jean-Louis Henri | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
US20030236212A1 (en) * | 2002-04-10 | 2003-12-25 | Jean-Louis Dasseux | Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses |
US20040048910A1 (en) * | 2002-08-22 | 2004-03-11 | Bove Susan Elizabeth | Method of treating osteoarthritis |
KR20050058454A (ko) * | 2002-08-22 | 2005-06-16 | 워너-램버트 캄파니 엘엘씨 | 골관절염의 치료 방법 |
US20040110803A1 (en) * | 2002-09-13 | 2004-06-10 | Hossein Dovlatabadi | Methods and compositions for the use of D-malic acid to decrease serum triglyceride, cholesterol and lipoprotein levels |
WO2004045596A1 (en) * | 2002-11-15 | 2004-06-03 | Warner-Lambert Company Llc | Method of lowering crp and reducing systemic inflammation |
ES2594340T3 (es) * | 2003-01-23 | 2016-12-19 | Esperion Therapeutics Inc. | Compuestos de hidroxilo y composiciones para el control del colesterol y utilizaciones correspondientes |
US20040229954A1 (en) * | 2003-05-16 | 2004-11-18 | Macdougall Diane Elaine | Selective manipulation of triglyceride, HDL and LDL parameters with 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt |
WO2005002557A1 (en) * | 2003-07-03 | 2005-01-13 | Warner-Lambert Company Llc | Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof |
US20050026979A1 (en) * | 2003-07-31 | 2005-02-03 | Maha Ghazzi | Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
DE602004020649D1 (de) * | 2003-11-07 | 2009-05-28 | Jj Pharma Inc | Hdl-verstärkende kombinationstherapie-komplexe |
US20050192347A1 (en) * | 2003-12-23 | 2005-09-01 | Dasseux Jean-Louis H. | Urea and thiourea compounds and compositions for cholesterol management and related uses |
AU2003304703A1 (en) | 2003-12-24 | 2005-08-03 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
WO2005068410A1 (en) * | 2003-12-24 | 2005-07-28 | Esperion Therapeutics, Inc. | Ether compounds and compositions for cholesterol management and related uses |
EP1753782A1 (en) * | 2004-06-09 | 2007-02-21 | Avanir Pharmaceuticals | Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
AU2005255011A1 (en) * | 2004-06-09 | 2005-12-29 | Avanir Pharmaceuticals | Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
CA2568539A1 (en) * | 2004-06-09 | 2005-12-29 | Avanir Pharmaceuticals | Small molecules for treatment of hypercholesterolemia and related diseases |
WO2006045010A2 (en) * | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
AU2006275514B2 (en) * | 2005-07-29 | 2012-04-05 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
WO2008018877A1 (en) * | 2006-08-11 | 2008-02-14 | Ssv Therapeutics, Inc. | Carnitine conjugates as dual prodrugs, methods of production and uses thereof |
DK2118074T3 (en) * | 2007-02-01 | 2014-03-10 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular diseases |
EP2167069B1 (en) | 2007-05-23 | 2011-10-26 | Amcol International Corporation | Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal |
US8101565B2 (en) * | 2007-09-20 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
US7985727B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Apo A-I mimetic peptides and methods of treatment |
US9173890B2 (en) * | 2007-09-20 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
US8044021B2 (en) * | 2007-09-20 | 2011-10-25 | Abbott Cardiovascular Systems Inc. | Sustained release of apo A-I mimetic peptides and methods of treatment |
US7985728B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
DK2346837T3 (en) | 2008-06-26 | 2015-04-20 | Resverlogix Corp | Methods for preparing quinazolinone derivatives |
ES2463097T3 (es) | 2009-01-08 | 2014-05-27 | Resverlogix Corp. | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
CA2754509C (en) | 2009-03-18 | 2018-03-06 | Resverlogix Corp. | Novel anti-inflammatory agents |
PT2421533T (pt) | 2009-04-22 | 2019-01-21 | Resverlogix Corp | Novos agentes anti-inflamatórios |
MX2012002639A (es) | 2009-09-03 | 2012-03-14 | Pfizer Vaccines Llc | Vacuna de pcsk9. |
JP2013537240A (ja) | 2010-09-20 | 2013-09-30 | カリウス セラピューティクス エスエー | 糖尿病および脂質異常症の処置のための方法および組成物 |
ES2646835T3 (es) | 2010-10-18 | 2017-12-18 | Cerenis Therapeutics Holding Sa | Compuestos, composiciones y procedimientos útiles para la movilización del colesterol |
PL2658536T3 (pl) | 2010-12-27 | 2017-04-28 | Gemphire Therapeutics Inc. | Gemcabene i pochodne do leczenia pancreatitis |
US20140004142A1 (en) | 2011-03-02 | 2014-01-02 | Pfizer Inc. | Pcsk9 vaccine |
HUE044986T2 (hu) | 2011-11-01 | 2019-11-28 | Resverlogix Corp | Orális, azonnali felszabadulású készítmények szubsztituált kinazolinonokhoz |
JP6295205B2 (ja) | 2012-01-06 | 2018-03-14 | ジェムファイア セラピューティクス インクGemphire Therapeutics Inc. | 心血管疾患のリスクを低減する方法 |
WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
JP2016507496A (ja) | 2012-12-21 | 2016-03-10 | ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. | ブロモドメイン阻害剤としての新規複素環式化合物 |
US10279019B2 (en) | 2014-02-11 | 2019-05-07 | Stc.Unm | PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same |
SG11201609084QA (en) | 2014-05-02 | 2016-11-29 | Cerenis Therapeutics Holding Sa | Hdl therapy markers |
KR20170083535A (ko) * | 2014-11-14 | 2017-07-18 | 젬파이어 세러퓨틱스 인코포레이티드 | α,ω-다이카복실산-말단 다이알케인 에터를 제조하기 위한 방법 및 중간체 |
JO3789B1 (ar) | 2015-03-13 | 2021-01-31 | Resverlogix Corp | التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة |
AU2016233485B2 (en) | 2015-03-13 | 2021-05-20 | Esperion Therapeutics, Inc. | Fixed dose combinations and formulations comprising ETC1002 and Ezetimibe and methods of treating or reducing the risk of cardiovascular disease |
MA41793A (fr) | 2015-03-16 | 2018-01-23 | Esperion Therapeutics Inc | Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire |
CA3001627A1 (en) | 2015-11-06 | 2017-05-11 | Gemphire Therapeutics, Inc. | Treatment of mixed dyslipidemia |
WO2018165120A1 (en) * | 2017-03-06 | 2018-09-13 | Gemphire Therapeutics Inc. | Effect of carboxyalkylethers on obesity symptoms and lipodystropy |
US20180297929A1 (en) * | 2017-04-18 | 2018-10-18 | Gemphire Therapeutics Inc. | Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor |
CA3144372A1 (en) | 2019-06-21 | 2020-12-24 | Esperion Therapeutics, Inc. | Salt forms of bempedoic acid and methods for using the same |
US11098002B2 (en) | 2019-07-26 | 2021-08-24 | Espervita Therapeutics, Inc. | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease |
WO2021262992A1 (en) | 2020-06-24 | 2021-12-30 | Neurobo Pharmaceuticals, Inc. | Gemcabene for treatment of cytokine storms and viral-induced inflammation |
WO2022159808A2 (en) | 2021-01-25 | 2022-07-28 | Espervita Therapeutics, Inc. | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease |
TW202245804A (zh) | 2021-01-25 | 2022-12-01 | 美商艾斯佩維他治療學公司 | 官能化長鏈烴單羧酸及二羧酸及其衍生物以及其於預防或治療疾病之用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2466419A (en) * | 1948-02-07 | 1949-04-05 | Eastman Kodak Co | beta, beta'-oxydipropionic acids and process of preparation |
US3320079A (en) * | 1960-07-11 | 1967-05-16 | Eastman Kodak Co | Ether-acid polyester composition |
US3431298A (en) * | 1965-01-05 | 1969-03-04 | Asahi Chemical Ind | Process for the preparation of oxadicarboxylic acids |
US3674836A (en) * | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
US3930024A (en) * | 1969-09-02 | 1975-12-30 | Parke Davis & Co | Pharmaceutical compositions and methods |
BE755997A (fr) * | 1969-09-11 | 1971-03-10 | Bp Chem Int Ltd | Production d'acides dicarboxyliques |
US3742068A (en) * | 1970-04-17 | 1973-06-26 | G Moersch | Ethers of 2,2,9,9-tetramethyl-1,10-decanediol |
IT1168389B (it) * | 1981-05-06 | 1987-05-20 | Alfa Farmaceutici Spa | Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono |
DE3423166A1 (de) * | 1984-06-22 | 1986-01-02 | Epis S.A., Zug | Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
IL84953A (en) * | 1987-12-28 | 1992-01-15 | Bromine Compounds Ltd | 3,3'-oxy-bis((2,2'-di(bromomethyl)propanoic acid)derivatives,processes for their preparation and their use as flame retardant agents |
DE3814498A1 (de) * | 1988-04-29 | 1989-11-09 | Basf Ag | Verfahren zur herstellung von hydroxicarbonsaeureestern |
US5395917A (en) * | 1993-05-21 | 1995-03-07 | E. I. Du Pont De Nemours And Company | Polyimides from 4-(3-aminophenoxy)benzoic acid |
-
1995
- 1995-03-24 US US08/409,780 patent/US5648387A/en not_active Expired - Lifetime
-
1996
- 1996-02-05 EP EP96903794A patent/EP0820428B1/en not_active Expired - Lifetime
- 1996-02-05 KR KR1019970706637A patent/KR100408612B1/ko not_active IP Right Cessation
- 1996-02-05 AU AU47768/96A patent/AU692359B2/en not_active Ceased
- 1996-02-05 DE DE69608268T patent/DE69608268T2/de not_active Expired - Lifetime
- 1996-02-05 PL PL96322407A patent/PL181673B1/pl not_active IP Right Cessation
- 1996-02-05 NZ NZ302170A patent/NZ302170A/en unknown
- 1996-02-05 CZ CZ19972922A patent/CZ289556B6/cs not_active IP Right Cessation
- 1996-02-05 ES ES96903794T patent/ES2148733T3/es not_active Expired - Lifetime
- 1996-02-05 WO PCT/US1996/001639 patent/WO1996030328A1/en active IP Right Grant
- 1996-02-05 DK DK96903794T patent/DK0820428T3/da active
- 1996-02-05 RU RU97118420/04A patent/RU2191772C2/ru not_active IP Right Cessation
- 1996-02-05 CA CA002215233A patent/CA2215233C/en not_active Expired - Fee Related
- 1996-02-05 JP JP52934296A patent/JP3885115B2/ja not_active Expired - Lifetime
- 1996-02-05 PT PT96903794T patent/PT820428E/pt unknown
- 1996-02-05 UA UA97105209A patent/UA46020C2/uk unknown
- 1996-02-05 SK SK1286-97A patent/SK282897B6/sk unknown
- 1996-02-05 HU HU9801825A patent/HUP9801825A3/hu unknown
- 1996-02-05 AT AT96903794T patent/ATE192732T1/de not_active IP Right Cessation
- 1996-02-05 EE EE9700375A patent/EE03520B1/xx not_active IP Right Cessation
- 1996-02-05 CN CN96193500A patent/CN1100747C/zh not_active Expired - Fee Related
- 1996-03-20 ZA ZA962275A patent/ZA962275B/xx unknown
-
1997
- 1997-02-25 US US08/805,533 patent/US5750569A/en not_active Expired - Lifetime
- 1997-02-25 US US08/806,580 patent/US5783600A/en not_active Expired - Lifetime
- 1997-02-25 US US08/806,582 patent/US5756544A/en not_active Expired - Lifetime
- 1997-09-17 FI FI973713A patent/FI973713A/fi not_active IP Right Cessation
- 1997-09-23 NO NO974397A patent/NO307878B1/no not_active IP Right Cessation
- 1997-10-24 BG BG101993A patent/BG63534B1/bg unknown
-
1998
- 1998-09-04 HK HK98110440A patent/HK1009438A1/xx not_active IP Right Cessation
-
2000
- 2000-08-02 GR GR20000401806T patent/GR3034109T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974397D0 (no) | Terminale karboksy- eller tetrazolgrupper inneholdende dialkyletere | |
FI910625A0 (fi) | Aetbar belagd komposition oh foerfarande foer dess framstaellning. | |
EP0659339A3 (en) | Sticky housing for insect trap. | |
FR2694497B1 (fr) | Desodorisant de table. | |
DE59102894D1 (de) | Kompakte Niederdruckentladungslampe. | |
AU2307695A (en) | High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base | |
FI951511A0 (fi) | IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon | |
EP0858262A4 (en) | THROMBIN INHIBITORS | |
DE69610980D1 (de) | Chemische komplexe | |
AU3850100A (en) | Placing unit for a human being | |
DE69407593T2 (de) | Polyisocyanatzusammensetzung | |
FI914426A (fi) | Foerfarande foer framstaellning av 1-( (2s)-3-merkaptometyl-1-oxopropyl)l-prolin. | |
ITRM930634A0 (it) | Complessi monoazoici del rame reattivi verso le fibre. (caso 150-5653) | |
ES2163503T3 (es) | Compuesto ge3. | |
FR2686894B1 (fr) | Bougie. | |
NL1002052A1 (nl) | Ballasttankinrichting. | |
IT219716Z2 (it) | Gruppo elettrico da muro, quale una luce notturna, un ricarica-pile e simili, avente una spiona destinata ad impegnare una presa a muro. | |
ES1014575Y (es) | Pantalla luminosa compacta, estanca, perfeccionada. | |
ITME950020A0 (it) | Impianto trattamento r.s.u. | |
ES1028663Y (es) | Depresor lingual. | |
KR950026063U (ko) | 향기 나는 테레비젼(t.v.) | |
IT231788Y1 (it) | Dispositivo elettronico modulare da incasso ripetitore di suoneria telefonica. | |
NO901767D0 (no) | Delvis neddykkbart fartoey. | |
KR970015514U (ko) | 송화기를 자외선 전등으로 소독하는 전화기 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |